Kodiak Sciences Inc.KODNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank62
5Y CAGR-15.8%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-15.8%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 18.04% |
| Q2 2025 | -2.03% |
| Q1 2025 | 37.37% |
| Q4 2024 | -0.33% |
| Q3 2024 | -1.96% |
| Q2 2024 | 8.63% |
| Q1 2024 | -35.81% |
| Q4 2023 | 28.85% |
| Q3 2023 | -45.96% |
| Q2 2023 | 18.47% |
| Q1 2023 | 0.94% |
| Q4 2022 | -9.21% |
| Q3 2022 | -16.36% |
| Q2 2022 | -3.19% |
| Q1 2022 | 0.77% |
| Q4 2021 | 34.99% |
| Q3 2021 | 23.34% |
| Q2 2021 | 12.56% |
| Q1 2021 | 7.98% |
| Q4 2020 | 27.47% |
| Q3 2020 | 42.56% |
| Q2 2020 | 1.92% |
| Q1 2020 | 57.21% |
| Q4 2019 | 26.84% |
| Q3 2019 | 14.45% |
| Q2 2019 | 54.43% |
| Q1 2019 | -16.46% |
| Q4 2018 | 45.49% |
| Q3 2018 | 31.13% |
| Q2 2018 | -1.40% |
| Q1 2018 | -58.50% |
| Q4 2017 | 178.78% |
| Q3 2017 | -37.65% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |